Page last updated: 2024-11-06

nordimaprit

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

nordimaprit: effective agonist in the inhibition of lymphocyte activation [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID85296
SCHEMBL ID7216548
MeSH IDM0085644

Synonyms (14)

Synonym
nordimaprit
carbamimidothioic acid, 2-(dimethylamino)ethyl ester
17124-82-2
AKOS006221645
2-(s-dimethylaminoethyl)isothiourea
skf-91487
sk&f 91487
MUYRPUKYVOXLSN-UHFFFAOYSA-N
2-(dimethylamino)ethyl imidothiocarbamate #
2-(dimethylaminoethyl) iminoaminomethyl sulfide
SCHEMBL7216548
2-(dimethylamino)ethyl carbamimidothioate
STARBLD0005051
DTXSID40864663

Research Excerpts

Dosage Studied

ExcerptRelevanceReference
" The dose-response curves of inhibition of mitogen-induced lymphocyte activation for chloroquine and methylamine are very steep and are similar to the dose-response curves obtained with dimaprit and nordimaprit, but very different from the flat dose-response curves previously described for histamine."( A comparison of dimaprit, nordimaprit, methylamine and chloroquine as inhibitors of mitogen-induced lymphocyte activation.
Dale, MM; Ladd, R, 1984
)
0.76
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (16)

TimeframeStudies, This Drug (%)All Drugs %
pre-19908 (50.00)18.7374
1990's6 (37.50)18.2507
2000's0 (0.00)29.6817
2010's2 (12.50)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.44

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.44 (24.57)
Research Supply Index2.83 (2.92)
Research Growth Index4.27 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.44)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies3 (18.75%)4.05%
Observational0 (0.00%)0.25%
Other13 (81.25%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]